Clinical Trials on Amyloidosis Cerebral
Total 4596 results
-
Stanford UniversityCompleted
-
M.D. Anderson Cancer CenterTakeda; Janssen PharmaceuticalsActive, not recruitingRecurrent Primary Amyloidosis | Refractory Primary Amyloidosis | Newly Diagnosed Primary AmyloidosisUnited States
-
Life Molecular Imaging GmbHpharmtrace klinische Entwicklung GmbHRecruitingAL Amyloidosis | Cardiac Amyloidosis | ATTR AmyloidosisUnited States, Spain, Germany, United Kingdom
-
Jian LiPeking University First Hospital; Tongji Hospital; Nanfang Hospital of Southern... and other collaboratorsCompletedAmyloidosis; SystemicChina
-
Pr. Nicolas GIRERDRecruitingTransthyretin Cardiac AmyloidosisFrance
-
Mayo ClinicCompletedTTR Cardiac AmyloidosisUnited States
-
Poitiers University HospitalPfizerCompletedTransthyretin Cardiac AmyloidosisFrance
-
Nexcella Inc.Not yet recruitingLight Chain (AL) AmyloidosisUnited States
-
Millennium Pharmaceuticals, Inc.TerminatedRelapsed or Refractory Systemic Light Chain AmyloidosisUnited States, Canada, Spain, Israel, France, Australia, Denmark, Germany, Korea, Republic of, Greece, Netherlands, Brazil, Czechia, Italy, United Kingdom
-
Paolo MilaniRecruitingAmyloidosis | Amyloidosis Cardiac | ATTR Amyloidosis Wild TypeItaly
-
Columbia UniversityAttralus, Inc.RecruitingTransthyretin AmyloidosisUnited States
-
Yale UniversityAlnylam Pharmaceuticals IncNot yet recruitingTransthyretin AmyloidosisUnited States
-
University Hospital, CaenPfizerRecruitingAmyloidosis TransthyretinFrance
-
Ionis Pharmaceuticals, Inc.CompletedHealthy Volunteers | hATTR AmyloidosisCanada
-
C.T. Development America, Inc.CompletedAmyloidosisSpain, United States, Italy, Belgium, Netherlands, India, Tunisia, Latvia, Turkey, France, Germany, Estonia, Lithuania, Poland, Russian Federation, Georgia, United Kingdom, Israel, Egypt, Finland, Peru, Sweden, Ukraine
-
Alnylam PharmaceuticalsCompletedA Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy VolunteersTransthyretin (TTR)-Mediated AmyloidosisUnited Kingdom
-
Nanjing University School of MedicineRecruiting
-
Jin Lu, MDRecruiting
-
University of TennesseeFDA Office of Orphan Products DevelopmentCompleted
-
Attralus, Inc.Novotech (Australia) Pty LimitedRecruitingAmyloidosis; SystemicUnited States, Australia, United Kingdom
-
Brigham and Women's HospitalRecruiting
-
University of EdinburghCompleted
-
University of Tennessee Graduate School of MedicineActive, not recruitingSystemic AmyloidosisUnited States
-
The Cleveland ClinicAvid RadiopharmaceuticalsTerminatedCardiac AmyloidosisUnited States
-
University Hospital Center of MartiniquePfizerUnknownCardiac AmyloidosisGuadeloupe, Martinique
-
Shahid Beheshti University of Medical SciencesCompleted
-
Assiut UniversityNot yet recruiting
-
Attralus, Inc.Novotech (Australia) Pty LimitedRecruitingAmyloidosis; SystemicUnited States, Australia
-
Saving Lives MattersRecruiting
-
Turkish Society of CardiologyRecruiting
-
Medical College of WisconsinTerminatedCardiac AmyloidosisUnited States
-
Brigham and Women's HospitalTerminatedCardiac AmyloidosisUnited States
-
University of MessinaCampisi MariapaolaUnknownCardiac AmyloidosisItaly
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Seoul National University HospitalCW pharmaceutical companyUnknownCardiac AmyloidosisKorea, Republic of
-
Virginia Commonwealth UniversityNot yet recruitingAmyloidosis, HereditaryUnited States
-
Oncology Institute of Southern SwitzerlandUniversity of Kiel; Ente Ospedaliero Cantonale, BellinzonaCompleted
-
University of PennsylvaniaAstraZeneca; Ionis Pharmaceuticals, Inc.Active, not recruitingHereditary Amyloidosis, Transthyretin-RelatedUnited States
-
Jeffrey ZonderNot yet recruiting
-
Rennes University HospitalRecruitingTransthyretin Amyloidosis | Amyloidosis, HereditaryFrance
-
Air Force Military Medical University, ChinaNot yet recruitingImmunoglobulin Light-chain Amyloidosis
-
PETHEMA FoundationCompletedPrimary Systemic AmyloidosisSpain
-
National Cancer Institute (NCI)TerminatedPrimary Systemic AmyloidosisUnited States
-
Alnylam PharmaceuticalsRecruitingTransthyretin-Mediated AmyloidosisUnited Kingdom
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Spain, Sweden, Brazil, United States, France, Germany
-
IRCCS Policlinico S. MatteoCompleted
-
Alnylam PharmaceuticalsCompleted
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited Kingdom